2012
DOI: 10.1016/j.bmcl.2012.03.053
|View full text |Cite
|
Sign up to set email alerts
|

Glucose–aspirin: Synthesis and in vitro anti-cancer activity studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
23
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 19 publications
(24 citation statements)
references
References 10 publications
0
23
0
1
Order By: Relevance
“…In the discovery of a superaspirin Jacob et al (2012) [110] synthesized by conjugation aspirin-glucose ( Figure 5) in order to study the solubility in water and anticancer activity as compared to aspirin and evaluated that aspirin-glucose was seven times more soluble in water than aspirin, and about 8 to 9 times more active in inhibiting cell growth than aspirin in its anticancer activity in cell culture breast, pancreatic, and cell lines prostate, while the activity was similar in a line benign non-cancer cells. According to the computer calculations performed to aspirin and aspirin-glucose in HF/6-31G** verified that the anticancer activity of aspirin-glucose was increased by the fact of presenting high value GAP = −0.43232 eV, having greater molecular stability and low chemical reactivity, being that the value of GAP to aspirin in HF/6-31G** was −0.43332 eV, having a variation of GAP = ±10 −3 eV (between aspirin and aspirin-glucose).…”
Section: Case Study On Aspirinmentioning
confidence: 99%
“…In the discovery of a superaspirin Jacob et al (2012) [110] synthesized by conjugation aspirin-glucose ( Figure 5) in order to study the solubility in water and anticancer activity as compared to aspirin and evaluated that aspirin-glucose was seven times more soluble in water than aspirin, and about 8 to 9 times more active in inhibiting cell growth than aspirin in its anticancer activity in cell culture breast, pancreatic, and cell lines prostate, while the activity was similar in a line benign non-cancer cells. According to the computer calculations performed to aspirin and aspirin-glucose in HF/6-31G** verified that the anticancer activity of aspirin-glucose was increased by the fact of presenting high value GAP = −0.43232 eV, having greater molecular stability and low chemical reactivity, being that the value of GAP to aspirin in HF/6-31G** was −0.43332 eV, having a variation of GAP = ±10 −3 eV (between aspirin and aspirin-glucose).…”
Section: Case Study On Aspirinmentioning
confidence: 99%
“…[4] [16] Sugar drug derivatives have opened a new gateway in the medical and pharmaceutical field and, currently, a great number of the drugs commonly in use rely on linkage of carbohydrates. [22] The ibuprofen-fructose ester showed extended stability in aqueous solution, and fewer adverse effects, enhanced tissue uptake in comparison with ibuprofen alone. [18] [19] Glycosidic conjugation also leads to better absorption [20] and penetration of drugs into the cell membranes, thus aiding delivery of drugs to the targeted site.…”
Section: Introductionmentioning
confidence: 99%
“…[22] The ibuprofen-fructose ester showed extended stability in aqueous solution, and fewer adverse effects, enhanced tissue uptake in comparison with ibuprofen alone. [26] Because the conjugation of drugs with saccharides presents multiple opportunities to improve bioavailability and pharmaceutical properties, [19] [22] monosaccharide derivatives of 5-ASA were prepared in this study to investigate the role of the glycoside conjugation on the biological properties of this drug. [24] For instance, galactose and fructose laurates have demonstrated excellent antibacterial effects against both Gram-positive and Gram-negative bacteria when compared with alternative analogues of synthesized fatty acid-carbohydrate esters.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations